I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Heaney, Mark L.
361
results:
Search for persons
X
Format
Online (361)
Mediatypes
Articles (Online) (122)
Bookchapter (Online) (9)
OpenAccess-fulltext (230)
Languages
english (335)
spanish (1)
Sorted by: Relevance
Sorted by: Year
?
1
Anagrelide for platelet-directed cytoreduction in polycythe..:
Rippel, Noa
;
Tremblay, Douglas
;
Zubizarreta, Nicole
...
Leukemia Research. 119 (2022) - p. 106903 , 2022
Link:
https://doi.org/10.1016/..
?
2
European LeukemiaNet Response Predicts Disease Progression ..:
Tremblay, Douglas
;
Srisuwananukorn, Andrew
;
Ronner, Lukas
...
HemaSphere. 6 (2022) 6 - p. e721 , 2022
Link:
https://doi.org/10.1097/..
?
3
Efficacy and safety of avapritinib in advanced systemic mas..:
Gotlib, Jason
;
Reiter, Andreas
;
Radia, Deepti H.
...
Nature Medicine. 27 (2021) 12 - p. 2192-2199 , 2021
Link:
https://doi.org/10.1038/..
?
4
Ruxolitinib discontinuation in polycythemia vera: Patient c..:
Tremblay, Douglas
;
Ronner, Lukas
;
Podoltsev, Nikolai
...
Leukemia Research. 109 (2021) - p. 106629 , 2021
Link:
https://doi.org/10.1016/..
?
5
ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion ..:
Oh, Stephen T.
;
Talpaz, Moshe
;
Gerds, Aaron T.
...
Blood Advances. 4 (2020) 18 - p. 4282-4291 , 2020
Link:
https://doi.org/10.1182/..
?
6
Phase 2 study of ruxolitinib and decitabine in patients wit..:
Mascarenhas, John O.
;
Rampal, Raajit K.
;
Kosiorek, Heidi E.
...
Blood Advances. 4 (2020) 20 - p. 5246-5256 , 2020
Link:
https://doi.org/10.1182/..
?
7
PIONEER: A Randomized, Double-Blind, Placebo-Controlled, Ph..:
Akin, Cem
;
Elberink, Hanneke Oude
;
Gotlib, Jason
...
Journal of Allergy and Clinical Immunology. 145 (2020) 2 - p. AB336 , 2020
Link:
https://doi.org/10.1016/..
?
8
Corrigendum to "Phase 1/2 trial of glasdegib in patients wi..:
Gerds, Aaron T.
;
Tauchi, Tetsuzo
;
Ritchie, Ellen
...
Leukemia Research. 81 (2019) - p. 105 , 2019
Link:
https://doi.org/10.1016/..
?
9
Phase 1/2 trial of glasdegib in patients with primary or se..:
Gerds, Aaron T.
;
Tauchi, Tetsuzo
;
Ritchie, Ellen
...
Leukemia Research. 79 (2019) - p. 38-44 , 2019
Link:
https://doi.org/10.1016/..
?
10
Safety and efficacy of combined ruxolitinib and decitabine ..:
Rampal, Raajit K.
;
Mascarenhas, John O.
;
Kosiorek, Heidi E.
...
Blood Advances. 2 (2018) 24 - p. 3572-3580 , 2018
Link:
https://doi.org/10.1182/..
?
11
Clonal diversity predicts adverse outcome in chronic lympho..:
Leeksma, Alexander C.
;
Taylor, Justin
;
Wu, Bian
...
Leukemia. 33 (2018) 2 - p. 390-402 , 2018
Link:
https://doi.org/10.1038/..
?
12
A Phase I Trial of a Pharmacodynamically-Conceived Thioguan..:
Lee, Daniel
;
Rosenblat, Todd
;
Heaney, Mark
...
Clinical Lymphoma Myeloma and Leukemia. 16 (2016) - p. S24 , 2016
Link:
https://doi.org/10.1016/..
?
13
A phase IIa study of afuresertib, an oral pan‐AKT inhibitor..:
Arceci, Robert J.
;
Allen, Carl E.
;
Dunkel, Ira J.
...
Pediatric Blood & Cancer. 64 (2016) 5 - p. , 2016
Link:
https://doi.org/10.1002/..
?
14
Zeroing in on cereblon:
Heaney, Mark L.
European Journal of Haematology. 95 (2015) 1 - p. 1-2 , 2015
Link:
https://doi.org/10.1111/..
?
15
Treatment Outcomes in CML Patients Treated With Tyrosine Ki..:
Sissolak, Gerhard
;
Badenhorst, Jacques
;
Steenkamp, Janami
...
Clinical Lymphoma Myeloma and Leukemia. 15 (2015) 12 - p. 803-810 , 2015
Link:
https://doi.org/10.1016/..
1-15